OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
235059

Saudi Kayan Petrochemical Company SJSC

Commodity ChemicalsVerified

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 1.0, indicating that its liabilities are equal to its equity. Liquidity is constrained, as evidenced by a current ratio of 0.85, suggesting that the company's current liabilities exceed its current assets. The company's cash and equivalents amount to SAR 56.26 million, which is significantly lower than its long-term debt of SAR 9.14 billion, resulting in a negative net cash position. Profitability is severely challenged, with a return on equity of -24.99% and a return on assets of -10.09%, both well below the typical performance of the commodity chemicals industry. The company reported a net loss of SAR 2.29 billion for the period, with operating income also in negative territory at SAR -1.64 billion. These figures indicate a significant underperformance relative to industry norms and highlight the company's current financial distress. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases the company's exposure to regional economic and regulatory risks. The absence of detailed segment reporting limits the ability to assess the performance of individual product lines or geographic regions. The company's growth trajectory is negative, with a net loss in the most recent reporting period and no indication of a turnaround in the near term. Analysts have assigned a mean price target of SAR 5.50, with a median of SAR 5.35, and a mean recommendation of 3.12, indicating a cautious outlook. The company's capital expenditures of SAR 647.84 million suggest ongoing investment, but the negative free cash flow of SAR -564.52 million indicates that these investments are not yet generating positive returns. The company faces significant financial risk, with a liquidity risk score of medium and a negative net cash position. The risk assessment also highlights the potential for dilution, although the current dilution risk is classified as low. The company's financial performance and leverage position suggest a high risk of further dilution if it requires additional capital to fund operations or reduce debt. Recent filings and transcripts indicate that the company is under pressure to improve its financial performance and reduce debt. The company has not disclosed any major strategic initiatives or cost-cutting measures in the latest reports, and the absence of strong buy recommendations from analysts suggests a lack of confidence in its near-term prospects.

30-day price · 2350+0.55 (+10.5%)
Low$5.09High$6.20Close$5.80As of21 May, 00:00 UTC
Profile
CompanySaudi Kayan Petrochemical Company SJSC
Ticker2350.SE
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Saudi Kayan Petrochemical Company SJSC is a Saudi Arabian company engaged in the production and sale of petrochemical products, primarily operating within the commodity chemicals industry.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92.

The company's capital structure is highly leveraged, with a debt-to-equity ratio of 1.0, indicating that its liabilities are equal to its equity. Liquidity is constrained, as evidenced by a current ratio of 0.85, suggesting that the company's current liabilities exceed its current assets. The company's cash and equivalents amount to SAR 56.26 million, which is significantly lower than its long-term debt of SAR 9.14 billion, resulting in a negative net cash position. Profitability is severely challenged, with a return on equity of -24.99% and a return on assets of -10.09%, both well below the typical performance of the commodity chemicals industry. The company reported a net loss of SAR 2.29 billion for the period, with operating income also in negative territory at SAR -1.64 billion. These figures indicate a significant underperformance relative to industry norms and highlight the company's current financial distress. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification increases the company's exposure to regional economic and regulatory risks. The absence of detailed segment reporting limits the ability to assess the performance of individual product lines or geographic regions. The company's growth trajectory is negative, with a net loss in the most recent reporting period and no indication of a turnaround in the near term. Analysts have assigned a mean price target of SAR 5.50, with a median of SAR 5.35, and a mean recommendation of 3.12, indicating a cautious outlook. The company's capital expenditures of SAR 647.84 million suggest ongoing investment, but the negative free cash flow of SAR -564.52 million indicates that these investments are not yet generating positive returns. The company faces significant financial risk, with a liquidity risk score of medium and a negative net cash position. The risk assessment also highlights the potential for dilution, although the current dilution risk is classified as low. The company's financial performance and leverage position suggest a high risk of further dilution if it requires additional capital to fund operations or reduce debt. Recent filings and transcripts indicate that the company is under pressure to improve its financial performance and reduce debt. The company has not disclosed any major strategic initiatives or cost-cutting measures in the latest reports, and the absence of strong buy recommendations from analysts suggests a lack of confidence in its near-term prospects.
Key takeaways
  • The company is highly leveraged, with a debt-to-equity ratio of 1.0 and a negative net cash position.
  • Profitability is severely challenged, with a return on equity of -24.99% and a return on assets of -10.09%.
  • The company's revenue is concentrated in a single business segment, increasing its exposure to regional and industry-specific risks.
  • Analysts have assigned a cautious outlook, with a mean price target of SAR 5.50 and a mean recommendation of 3.12.
  • The company's liquidity is constrained, with a current ratio of 0.85 and negative free cash flow.
  • The company faces significant financial risk, with a liquidity risk score of medium and a high risk of further dilution if it requires additional capital.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencySAR
Revenue$8.46B
Gross profit-$893.9M
Operating income-$1.64B
Net income-$2.29B
R&D
SG&A
D&A
SBC
Operating cash flow-$302.7M
CapEx-$647.8M
Free cash flow-$564.5M
Total assets$22.72B
Total liabilities$13.54B
Total equity$9.18B
Cash & equivalents$56.3M
Long-term debt$9.14B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$8.46B-$1.64B-$2.29B-$564.5M
FY-1$8.73B-$1.13B-$1.80B-$46.4M
FY-2$8.17B-$1.45B-$2.14B-$464.3M
FY-3$11.16B-$857.3M-$1.24B$801.7M
FY-4$12.66B$2.79B$2.39B$4.39B
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$22.72B$9.18B$56.3M
FY-1$24.87B$11.50B$247.8M
FY-2$26.68B$13.28B$477.0M
FY-3$28.27B$15.48B$358.5M
FY-4$32.90B$16.47B$97.2M
PeriodOCFCapExFCFSBC
FY0-$302.7M-$647.8M-$564.5M
FY-1$2.11B-$693.2M-$46.4M
FY-2$884.5M-$787.6M-$464.3M
FY-3$3.18B-$354.5M$801.7M
FY-4$3.83B-$423.4M$4.39B
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$1.49B-$614.6M
FQ-1$2.01B-$525.4M-$685.5M-$403.0M
FQ-2$2.15B-$163.1M-$336.2M$111.4M
FQ-3$2.23B-$305.8M-$496.4M-$26.4M
FQ-4$2.06B-$648.9M-$775.8M-$246.5M
FQ-5$2.25B-$522.6M-$685.6M-$250.9M
FQ-6$2.40B-$126.5M-$296.2M$152.1M
FQ-7$2.11B-$91.3M-$250.1M$205.3M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$8.54B
FQ-1$22.72B$9.18B$171.0M
FQ-2$23.62B$9.88B$532.8M
FQ-3$23.94B$10.24B$611.9M
FQ-4$24.17B$10.73B$530.5M
FQ-5$24.87B$11.50B$296.4M
FQ-6$25.11B$12.15B$300.3M
FQ-7$25.87B$12.51B$596.8M
PeriodOCFCapExFCFSBC
FQ0
FQ-1-$302.7M-$647.8M-$403.0M
FQ-2-$215.5M-$362.1M$111.4M
FQ-3-$304.6M-$199.7M-$26.4M
FQ-4-$535.3M-$64.5M-$246.5M
FQ-5$2.11B-$693.2M-$250.9M
FQ-6$1.27B-$523.3M$152.1M
FQ-7$1.12B-$349.6M$205.3M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$9.18B
Net cash-$9.08B
Current ratio0.8
Debt/Equity1.0
ROA-10.1%
ROE-25.0%
Cash conversion13.0%
CapEx/Revenue-7.7%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric2350Activity
Op margin-19.4%0.4% medp25 -8.0% · p75 16.0%bottom quartile
Net margin-27.1%2.3% medp25 -11.6% · p75 11.8%bottom quartile
Gross margin-10.6%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-7.7%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity100.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target5.50 SAR
Median price target5.35 SAR
High price target7.70 SAR
Low price target4.36 SAR
Mean recommendation3.12 (1=strong buy, 5=strong sell)
Strong-buy count0.00
Buy count2.00
Hold count3.00
Sell count3.00
Strong-sell count0.00
Mean EPS estimate-1.04 SAR
Last actual EPS-1.53 SAR
Source: analysis-pipeline (hybrid)Generated: 2026-05-19 00:48 UTCJob: 8276eedc